ArticleCancer research communications2024

Beyond HRD Status: Unraveling Genetic Variants Impacting PARP Inhibitor Sensitivity in Advanced Ovarian Cancer.

Maj K Kjeldsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.